In the BioHarmony Drug Report Database

"Preview" Icon

Melphalan

Alkeran, Phelinun (melphalan) is a small molecule pharmaceutical. Melphalan was first approved as Alkeran on 1982-01-01. It is used to treat breast neoplasms, multiple myeloma, neuroblastoma, ovarian neoplasms, and rhabdomyosarcoma in the USA. It has been approved in Europe to treat hematopoietic stem cell transplantation, hodgkin disease, multiple myeloma, myeloid leukemia acute, and neuroblastoma amongst others.

 

Trade Name

 

Phelinun
 

Common Name

 

melphalan
 

ChEMBL ID

 

CHEMBL852
 

Indication

 

breast neoplasms, hematopoietic stem cell transplantation, hodgkin disease, multiple myeloma, myeloid leukemia acute, neuroblastoma, non-hodgkin lymphoma, ovarian neoplasms, precursor cell lymphoblastic leukemia-lymphoma, rhabdomyosarcoma
 

Drug Class

 

Image (chem structure or protein)

Melphalan structure rendering